MetaCap

ProMIS Neurosciences (PMN) News

NASDAQ: PMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.16-0.05 (-1.56%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PMN news summary

We found 9 recent headlines mentioning ProMIS Neurosciences (PMN): 2 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, PMN is down 1.56% at $3.16. The most recent story, "ProMIS Licenses TXP1 From Ossianix To Deliver Alzheimer's & Parkinson's Therapies To Brain", was published by Nasdaq on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ProMIS Neurosciences headlines

Stocks mentioned alongside PMN

Compare PMN